Risk factors for cutaneous squamous cell carcinoma recurrence,metastasis, and disease-specific death: A systematic review and meta-analysis

JAMA Dermatology

Volumn 152, Issue 4, 2016, Pages 419-428

  Thompson, Agnieszka K ^a   Kelley, Benjamin F ^a   Prokop, Larry J ^a   Murad, M Hassan ^a   Baum, Christian L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; HUMAN; IMMUNE DEFICIENCY; METASTASIS; PERINEURAL INVASION; PRIORITY JOURNAL; RECURRENCE RISK; RISK ASSESSMENT; RISK FACTOR; SKIN CARCINOMA; SUBCUTANEOUS FAT; SYSTEMATIC REVIEW; TUMOR INVASION; TUMOR LOCALIZATION; TUMOR VOLUME; CARCINOMA, SQUAMOUS CELL; GENETIC PREDISPOSITION; META ANALYSIS; PATHOLOGY; SKIN NEOPLASMS; TUMOR RECURRENCE;

CARCINOMA, SQUAMOUS CELL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; SKIN NEOPLASMS;

EID: 84963745390     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2015.4994     Document Type: Article

References (50)

1. Karia PS, Han J, Schmults CD. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J AmAcad Dermatol. 2013;68(6):957-966.
2. Rogers HW,Weinstock MA, Harris AR, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol. 2010; 146(3):283-287.
3. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med. 2001;344(13):975-983.
4. Brantsch KD, Meisner C, Schönfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008;9(8):713-720.
5. Brougham ND, Dennett ER, Cameron R, Tan ST. The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors. J Surg Oncol. 2012;106(7):811-815.
6. Karia PS, Jambusaria-Pahlajani A, Harrington DP, Murphy GF, Qureshi AA, Schmults CD. Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham andWomen's Hospital tumor staging for cutaneous squamous cell carcinoma. J Clin Oncol. 2014;32(4):327-334.
7. Mourouzis C, Boynton A, Grant J, et al. Cutaneous head and neck SCCs and risk of nodal metastasis: UK experience. J Craniomaxillofac Surg. 2009;37(8):443-447.
8. Schmults CD, Karia PS, Carter JB, Han J, Qureshi AA. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. JAMA Dermatol. 2013;149(5):541-547.
9. Deeks JJ, Dinnes J, D'Amico R, et al; International Stroke Trial Collaborative Group; European Carotid Surgery Trial Collaborative Group. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7(27):iii-x, 1-173.
10. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188.
11. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency inmeta-analyses. BMJ. 2003;327(7414):557-560.
12. Dinehart SM, Pollack SV.Metastases from squamous cell carcinoma of the skin and lip: an analysis of twenty-seven cases. J AmAcad Dermatol. 1989;21(2, pt 1):241-248.
13. Dormand EL, Ridha H, VeselyMJ. Long-term outcome of squamous cell carcinoma of the upper and lower limbs. J Plast Reconstr Aesthet Surg. 2010;63(10):1705-1711.
14. Goepfert H, Dichtel WJ, Medina JE, Lindberg RD, Luna MD. Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg. 1984;148(4):542-547.
15. Quaedvlieg PJ, Creytens DH, Epping GG, et al. Histopathological characteristics ofmetastasizing squamous cell carcinoma of the skin and lips. Histopathology. 2006;49(3):256-264.
16. Brinkman JN, Hajder E, van der Holt B, Den Bakker MA, Hovius SE, Mureau MA. The effect of differentiation grade of cutaneous squamous cell carcinoma on excision margins, local recurrence, metastasis, and patient survival: a retrospective follow-up study. Ann Plast Surg. 2015;75(3):323-326.
17. Eroǧlu A, Berberoǧlu U, Berreroǧlu S. Risk factors related to locoregional recurrence in squamous cell carcinoma of the skin. J Surg Oncol. 1996;61(2):124-130.
18. Faustina M, Diba R, Ahmadi MA, Esmaeli B. Patterns of regional and distant metastasis in patients with eyelid and periocular squamous cell carcinoma. Ophthalmology. 2004;111(10):1930-1932.
19. Gonzalez A, Etchichury D, Creydt MP, Rivero M, Arizmendi CS. Prognostic factors for local recurrence and lymph node metastasis in cutaneous squamous cell carcinoma of the head and neck treated with Mohs surgery. In: Abstracts of the XVWorld Congress on Cancers of the Skin, 3-6 September 2014. Edinburgh, Scotland. Br J Dermatol. 2014;171(suppl 4):59-60.
20. Griffiths R W, Feeley K, Suvarna SK. Audit of clinical and histological prognostic factors in primary invasive squamous cell carcinoma of the skin: assessment in aminimum 5 year follow-up study after conventional excisional surgery. Br J Plast Surg. 2002;55(4):287-292.
21. Pugliano-Mauro M, Goldman G. Mohs surgery is effective for high-risk cutaneous squamous cell carcinoma. Dermatol Surg. 2010;36(10):1544-1553.
22. Immerman SC, Scanlon EF, Christ M, Knox KL. Recurrent squamous cell carcinoma of the skin. Cancer. 1983;51(8):1537-1540.
23. Mehrany K,Weenig RH, PittelkowMR, Roenigk RK, Otley CC. High recurrence rates of squamous cell carcinoma after Mohs' surgery in patients with chronic lymphocytic leukemia. Dermatol Surg. 2005;31(1):38-42.
24. Metchnikoff C, Mully T, Singer JP, Golden JA, Arron ST. The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients. J AmAcad Dermatol. 2012;67 (5):829-835.
25. Moore BA,Weber RS, Prieto V, et al. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope. 2005;115(9):1561-1567.
26. Mullen JT, Feng L, Xing Y, et al. Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann Surg Oncol. 2006;13(7):902-909.
27. Peat B, Insull P, Ayers R. Risk stratification for metastasis from cutaneous squamous cell carcinoma of the head and neck. ANZ J Surg. 2012; 82(4):230-233.
28. Toll A, Gimeno-Beltrán J, Ferrandiz-Pulido C, et al. D2-40 immunohistochemical overexpression in cutaneous squamous cell carcinomas: a marker of metastatic risk. J AmAcad Dermatol. 2012;67(6): 1310-1318.
29. Baker NJ,Webb AA, Macpherson D. Surgical management of cutaneous squamous cell carcinoma of the head and neck. Br J Oral Maxillofac Surg. 2001;39(2):87-90.
30. Cherpelis BS, Marcusen C, Lang PG. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg. 2002;28(3):268-273.
31. Clayman GL, Lee JJ, Holsinger FC, et al. Mortality risk from squamous cell skin cancer. J Clin Oncol. 2005;23(4):759-765.
32. Kyrgidis A, Tzellos TG, Kechagias N, et al. Cutaneous squamous cell carcinoma (SCC) of the head and neck: risk factors of overall and recurrence-free survival. Eur J Cancer. 2010;46(9): 1563-1572.
33. Leibovitch I, Huilgol SC, Selva D, Hill D, Richards S, Paver R. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia, II: perineural invasion. J AmAcad Dermatol. 2005;53(2):261-266.
34. Roozeboom MH, Lohman BG,Westers-Attema A, et al. Clinical and histological prognostic factors for local recurrence and metastasis of cutaneous squamous cell carcinoma: analysis of a defined population. Acta Derm Venereol. 2013;93(4):417-421.
35. Pereira MF, Morgado MA. Cryosurgery of malignant cutaneous tumours: ten years experience. Skin Cancer. 1994;9(4):179-185.
36. Harwood CA, Proby CM, McGregor JM, Sheaff MT, Leigh IM, Cerio R. Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J AmAcad Dermatol. 2006;54(2):290-300.
37. Friedman HI, Cooper PH,Wanebo HJ. Prognostic and therapeutic use of microstaging of cutaneous squamous cell carcinoma of the trunk and extremities. Cancer. 1985;56(5):1099-1105.
38. Breuninger H, Black B, Rassner G. Microstaging of squamous cell carcinomas. Am J Clin Pathol. 1990;94(5):624-627.
39. Krediet JT, Beyer M, Lenz K, et al. Sentinel lymph node biopsy and risk factors for predicting metastasis in cutaneous squamous cell carcinoma. Br J Dermatol. 2015;172(4):1029-1036.
40. Wermker K, Kluwig J, Schipmann S, Klein M, Schulze HJ, Hallermann C. Prediction score for lymph node metastasis from cutaneous squamous cell carcinoma of the external ear. Eur J Surg Oncol. 2015;41(1):128-135.
41. Vasconcelos L, Melo JC, Miot HA, Marques ME, Abbade LP. Invasive head and neck cutaneous squamous cell carcinoma: clinical and histopathological characteristics, frequency of local recurrence and metastasis. An Bras Dermatol. 2014; 89(4):562-568.
42. Stein AL, Tahan SR. Histologic correlates of metastasis in primary invasive squamous cell carcinoma of the lip. J Cutan Pathol. 1994;21(1):16-21.
43. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence,metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection. J AmAcad Dermatol. 1992;26(6):976-990.
44. Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer-Verlag; 2010.
45. Sobin LH, Gospodarowicz MK, Wittekind C, eds. TNM Classification of Malignant Tumours. 7th ed. Chichester, England: Wiley-Blackwell; 2010.
46. Jambusaria-Pahlajani A, Kanetsky PA, Karia PS, et al. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system. JAMA Dermatol. 2013;149(4):402-410.
47. Dinehart SM, Peterson S. Evaluation of the American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma and proposal of a new staging system. Dermatol Surg. 2005;31(11, pt 1):1379-1384.
48. Carter JB, Johnson MM, Chua TL, Karia PS, Schmults CD. Outcomes of primary cutaneous squamous cell carcinoma with perineural invasion: an 11-year cohort study. JAMA Dermatol. 2013;149 (1):35-41.
49. Schmidt C, Martin JM, Khoo E, Plank A, Grigg R. Outcomes of nodal metastatic cutaneous squamous cell carcinoma of the head and neck treated in a regional center. Head Neck. 2015;37 (12):1808-1815.
50. Weinberg AS, Ogle CA, Shim EK. Metastatic cutaneous squamous cell carcinoma: an update. Dermatol Surg. 2007;33(8):885-899.